
'Abuse of power': Senators call out 'shady tactics' after investigating Pfizer, Lilly DTC platforms
After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of senators has released a report suggesting the platforms may allow pharmas to inappropriately influence doctors’ prescribing habits. …